nach oben

Erschienen in:

26.11.2019 | Original Article

Different cortical excitability profiles in hereditary brain iron and copper accumulation

verfasst von: Raffaele Dubbioso, Lucia Ruggiero, Marcello Esposito, Paola Tarantino, Marcello De Angelis, Francesco Aruta, Sabina Pappatà, Lorenzo Ugga, Alberto Piperno, Raffaele Iorio, Lucio Santoro, Rosa Iodice, Fiore Manganelli

Erschienen in: Neurological Sciences | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Background and aim

Neurodegeneration with brain iron accumulation (NBIA) and Wilson’s disease (WD) is considered the prototype of neurodegenerative disorders characterised by the overloading of iron and copper in the central nervous system. Growing evidence has unveiled the involvement of these metals in brain cortical neurotransmission. Aim of this study was to assess cortical excitability profile due to copper and iron overload.

Methods

Three patients affected by NBIA, namely two patients with a recessive hereditary parkinsonism (PARK9) and one patient with aceruloplasminemia and 7 patients with neurological WD underwent transcranial magnetic stimulation (TMS) protocols to assess cortical excitability. Specifically, we evaluated the motor thresholds that reflect membrane excitability related to the voltage-gated sodium channels in the neurons of the motor system and the ease of activation of motor cortex via glutamatergic networks, and ad hoc TMS protocols to probe inhibitory-GABAergic (short interval intracortical inhibition, SICI; short-latency afferent inhibition, SAI; cortical silent period, CSP) and excitatory intracortical circuitry (intracortical facilitation, ICF).

Results

Patients with NBIA exhibited an abnormal prolongation of CSP respect to HC and WD patients. On the contrary, neurological WD displayed higher motor thresholds and reduced CSP and SICI.

Conclusion

Hereditary conditions due to overload of copper and iron exhibited peculiar cortical excitability profiles that can help during differential diagnosis between these conditions. Moreover, such results can give us more clues about the role of metals in acquired neurodegenerative disorders, such as Parkinson disease, Alzheimer disease, and multiple sclerosis.

Kozlowski H, Luczkowski M, Remelli M, Valensin D (2012) Copper, zinc and iron in neurodegenerative diseases (Alzheimer’s, Parkinson’s andprion diseases). Coord Chem Rev:2129–2141. https://doi.org/10.1016/j.ccr.2012.03.013

Tecchio F, Assenza G, Zappasodi F et al (2011) Glutamate-mediated primary somatosensory cortex excitability correlated with circulating copper and ceruloplasmin. Int J Alzheimers Dis:292593. https://doi.org/10.4061/2011/292593

Du M, Wang D (2009) The neurotoxic effects of heavy metal exposure on GABAergic nervous system in nematode Caenorhabditis elegans. Environ Toxicol Pharmacol 27:314–320. https://doi.org/10.1016/j.etap.2008.11.011CrossRefPubMed

McGee TP, Houston CM, Brickley SG (2013) Copper block of extrasynaptic GABAA receptors in the mature cerebellum and striatum. J Neurosci 33:13431–13435. https://doi.org/10.1523/jneurosci.1908-13.2013CrossRefPubMedPubMedCentral

Ye Q, Trivedi M, Zhang Y, Böhlke M, Alsulimani H, Chang J, Maher T, Deth R, Kim J (2019) Brain iron loading impairs DNA methylation and alters GABAergic function in mice. FASEB J 33:2460–2471. https://doi.org/10.1096/fj.201801116RRCrossRefPubMed

Ziemann U, Reis J, Schwenkreis P et al (2015) TMS and drugs revisited 2014. Clin Neurophysiol 126:1847–1868. https://doi.org/10.1016/j.clinph.2014.08.028CrossRefPubMed

Dubbioso R, Esposito M, Peluso S et al (2017) Disruption of GABA(A)-mediated intracortical inhibition in patients with chorea-acanthocytosis. Neurosci Lett 654:107–110. https://doi.org/10.1016/j.neulet.2017.06.032CrossRefPubMed

Dubbioso R, Ranucci G, Esposito M et al (2016) Subclinical neurological involvement does not develop if Wilson’s disease is treated early. Parkinsonism Relat Disord 24:15–19. https://doi.org/10.1016/j.parkreldis.2016.01.024CrossRefPubMed

Santoro L, Breedveld GJ, Manganelli F, Iodice R, Pisciotta C, Nolano M, Punzo F, Quarantelli M, Pappatà S, di Fonzo A, Oostra BA, Bonifati V (2011) Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability. Neurogenetics 12:33–39. https://doi.org/10.1007/s10048-010-0259-0CrossRefPubMed

10.

Rossini PM, Burke D, Chen R, Cohen LG, Daskalakis Z, di Iorio R, di Lazzaro V, Ferreri F, Fitzgerald PB, George MS, Hallett M, Lefaucheur JP, Langguth B, Matsumoto H, Miniussi C, Nitsche MA, Pascual-Leone A, Paulus W, Rossi S, Rothwell JC, Siebner HR, Ugawa Y, Walsh V, Ziemann U (2015) Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: basic principles and procedures for routine clinical and research application: An updated report from an I.F.C.N. Committee. Clin Neurophysiol 126:1071–1107. https://doi.org/10.1016/j.clinph.2015.02.001CrossRefPubMedPubMedCentral

11.

Dubbioso R, Raffin E, Karabanov A et al (2017) Centre-surround organization of fast sensorimotor integration in human motor hand area. Neuroimage 158:37–47. https://doi.org/10.1016/j.neuroimage.2017.06.063CrossRefPubMed

12.

Picillo M, Dubbioso R, Iodice R, Iavarone A, Pisciotta C, Spina E, Santoro L, Barone P, Amboni M, Manganelli F (2015) Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait. J Neural Transm 122:1533–1540. https://doi.org/10.1007/s00702-015-1428-yCrossRefPubMed

13.

Di Lazzaro V, Manganelli F, Dileone M et al (2012) The effects of prolonged cathodal direct current stimulation on the excitatory and inhibitory circuits of the ipsilateral and contralateral motor cortex. J Neural Transm 119. https://doi.org/10.1007/s00702-012-0845-4

14.

Dubbioso R, Pellegrino G, Antenora A et al (2015) The effect of cerebellar degeneration on human sensori-motor plasticity. Brain Stimul 8:1144–1150. https://doi.org/10.1016/j.brs.2015.05.012CrossRefPubMed

15.

Pelucchi S, Mariani R, Ravasi G et al (2018) Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia. Parkinsonism Relat Disord 51:36–42. https://doi.org/10.1016/j.parkreldis.2018.02.036CrossRefPubMed

16.

Dubbioso R, Pappatà S, Quarantelli M et al (2013) Atypical clinical and radiological presentation of cryptococcal choroid plexitis in an immunocompetent woman. J Neurol Sci 334. https://doi.org/10.1016/j.jns.2013.08.010

17.

Dubbioso R, Moretta P, Manganelli F, Fiorillo C, Iodice R, Trojano L, Santoro L (2012) Executive functions are impaired in heterozygote patients with oculopharyngeal muscular dystrophy. J Neurol 259. https://doi.org/10.1007/s00415-011-6255-y

18.

Manganelli F, Pisciotta C, Dubbioso R et al (2011) Electrophysiological characterisation in hereditary spastic paraplegia type 5. Clin Neurophysiol 122. https://doi.org/10.1016/j.clinph.2010.10.025

19.

Iodice R, Dubbioso R, Topa A, Ruggiero L, Pisciotta C, Esposito M, Tozza S, Santoro L, Manganelli F (2015) Electrophysiological characterization of adult-onset Niemann-Pick type C disease. J Neurol Sci 348:262–265. https://doi.org/10.1016/j.jns.2014.12.005CrossRefPubMed

20.

Cantello R, Gianelli M, Bettucci D, Civardi C, de Angelis MS, Mutani R (1991) Parkinson’s disease rigidity: magnetic motor evoked potentials in a small hand muscle. Neurology 41:1449–1456CrossRef

21.

Haug BA, Schönle PW, Knobloch C, Köhne M (1992) Silent period measurement revives as a valuable diagnostic tool with transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol Evoked Potentials 85:158–160. https://doi.org/10.1016/0168-5597(92)90081-LCrossRefPubMed

22.

Restivo DA (2004) Cortical silent period prolongation in spinocerebellar. Funct Neurol 19:37–41PubMed

23.

Loetscher T, Macdonell RAL, Brodtmann A (2012) Cortical excitability and neurology : insights into the pathophysiology. Funct Neurol 27:131–145PubMed

24.

McNeill A, Birchall D, Hayflick SJ, Gregory A, Schenk JF, Zimmerman EA, Shang H, Miyajima H, Chinnery PF (2008) T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 70:1614–1619. https://doi.org/10.1212/01.wnl.0000310985.40011.d6CrossRefPubMedPubMedCentral

25.

Schneider SA, Paisan-ruiz C, Quinn NP et al (2010) ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. Mov Disord 25:979–984. https://doi.org/10.1002/mds.22947CrossRefPubMed

26.

Cantello R, Tarletti R, Civardi C (2002) Transcranial magnetic stimulation and Parkinson’s disease. Brain Res Rev 38:309–327CrossRef

27.

Lefaucheur JP, Menard-Lefaucheur I, Maison P et al (2006) Electrophysiological deterioration over time in patients with Huntington’s disease. Mov Disord 21:1350–1354. https://doi.org/10.1002/mds.20966CrossRefPubMed

28.

Zittel S, Kroeger J, van der Vegt JPM et al (2012) Motor pathway excitability in ATP13A2 mutation carriers: a transcranial magnetic stimulation study. Parkinsonism Relat Disord 18:590–594. https://doi.org/10.1016/j.parkreldis.2011.10.020CrossRefPubMed

29.

Brüggemann N, Hagenah J, Reetz K et al (2010) Recessively inherited parkinsonism: Effect of ATP13A2 mutations on the clinical and neuroimaging phenotype. Arch Neurol 67:1357–1363. https://doi.org/10.1001/archneurol.2010.281CrossRefPubMed

30.

Manganelli F, Dubbioso R, Iodice R, Topa A, Dardis A, Russo CV, Ruggiero L, Tozza S, Filla A, Santoro L (2014) Central cholinergic dysfunction in the adult form of Niemann Pick disease type C: a further link with Alzheimer’s disease? J Neurol 261:804–808. https://doi.org/10.1007/s00415-014-7282-2CrossRefPubMed

31.

Dubbioso R, Manganelli F, Siebner HR, Di Lazzaro V (2019) Fast intracortical sensory-motor integration: a window into the pathophysiology of Parkinson’s disease. Front Hum Neurosci 13:111. https://doi.org/10.3389/fnhum.2019.00111CrossRefPubMedPubMedCentral

32.

Chen P, Miah M, Aschner M (2016) Metals and neurodegeneration. F1000Res 5. https://doi.org/10.12688/f1000research.7431.1

Titel: Different cortical excitability profiles in hereditary brain iron and copper accumulation
verfasst von: Raffaele Dubbioso
Lucia Ruggiero
Marcello Esposito
Paola Tarantino
Marcello De Angelis
Francesco Aruta
Sabina Pappatà
Lorenzo Ugga
Alberto Piperno
Raffaele Iorio
Lucio Santoro
Rosa Iodice
Fiore Manganelli
Publikationsdatum: 26.11.2019
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 3/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-019-04147-0

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Different cortical excitability profiles in hereditary brain iron and copper accumulation

Abstract

Background and aim

Methods

Results

Conclusion

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Abstract

Background and aim

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Palliative care in 9 children with neurodegeneration with brain iron accumulation

Cognitive impairment before and after intracerebral haemorrhage: a systematic review

NIHSS as predictor of clinical outcome at 6 months in patients with intracerebral hemorrhage

Steroid pulse therapy of radiological disease activity without clinical relapse in CLIPPERS

HMGB1 as a potential new marker of disease activity in patients with multiple sclerosis

Incidence of primary vesicoureteral reflux in patients with febrile convulsions

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie